Tag Archives: Only

ICUs are nearing capacity in this French city. And it’s only September

That’s how Dr. Olivier Joannes-Boyau, head of the intensive care unit at University Hospital in the southwestern city of Bordeaux, describes the resurgence of Covid-19 in France. After young French people took advantage of the lifting of lockdown and summer months to socialize freely, Covid-19 hospitalizations have risen in large cities like Paris, Bordeaux and… Read More: ICUs are nearing capacity in this French city. And it’s… »

The pandemic has only further strengthened my passion to become a physician

As a first-year medical student, the transition to an online curriculum has posed a unique set of challenges. I am often asked, “How exactly can you become a doctor without having seen a patient, without having put a stethoscope on another human being?” I’ve been told many times already by my professors that to listen… Read More: The pandemic has only further strengthened my passion to become… »

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More: FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First… »

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5